Core Viewpoint - FibroBiologics, Inc. has announced a definitive agreement for the issuance and sale of common stock and pre-funded warrants to an existing shareholder, aiming to strengthen its capital structure and support its pipeline of chronic disease therapeutics [1][2]. Financing Details - The company will issue 3,540,000 shares of common stock and pre-funded warrants to purchase 8,570,203 shares at a price of $0.3303 per share or warrant, totaling expected gross proceeds of approximately $4 million [1][5]. - The purchase price will be paid with sovereign-issued .9999 fine gold coins valued at $4,069.18 per ounce, which the company plans to liquidate into U.S. dollars [3]. Warrants and Stockholder Approval - In a concurrent private placement, unregistered warrants will be issued to purchase one share for each share or pre-funded warrant purchased, potentially allowing for an additional gross proceeds of approximately $4 million if exercised [4][5]. - The unregistered warrants will have an exercise price of $0.3303 per share and will require stockholder approval for the issuance of shares upon exercise [4]. Regulatory Compliance - The offering is being conducted under a shelf registration statement previously filed with the SEC, and the final prospectus supplement will be made available [6]. - The unregistered warrants are offered under Section 4(a)(2) of the Securities Act and have not been registered, limiting their sale in the U.S. [7]. Company Overview - FibroBiologics is a clinical-stage biotechnology company focused on developing therapeutics for chronic diseases using fibroblast cells, holding over 270 patents [10].

Core Points - Senmiao Technology Limited has entered into a securities purchase agreement with accredited investors for the issuance of 1,350,000 shares of common stock and pre-funded warrants to purchase 905,000 shares at a price of $1.26 per share, resulting in gross proceeds of approximately $2.8 million [1] - The company will also issue warrants to purchase up to 4,510,000 shares of common stock, which will require stockholder approval and have a term of 5.5 years with an exercise price of $1.26 per share [1][4] - The closing of the sale of shares is expected around November 17, 2025, subject to customary closing conditions [1] Company Use of Proceeds - The net proceeds from the offering will be used for general corporate purposes and working capital [2] Regulatory Information - The shares are being offered under a "shelf" registration statement on Form S-3, effective since September 29, 2023, and a prospectus supplement will be filed with the SEC [3] - The warrants and warrant shares will be offered under an exemption from registration requirements of the Securities Act, and a registration statement on Form S-1 will be filed for the resale of warrant shares within 30 days after the special meeting [4] Company Overview - Senmiao Technology Limited, headquartered in Chengdu, Sichuan Province, provides automobile transaction and related services, including sales of automobiles, financing facilitation, management, operating leases, and guarantees in China [6]

Core Viewpoint - Bitdeer Technologies Group has announced a registered direct offering of 10,661,140 Class A ordinary shares at a price of US$13.94 per share, aiming to raise approximately US$148.4 million in net proceeds, which will be used for various corporate purposes including debt repayment and business expansion [1][2][3]. Group 1: Offering Details - The registered direct offering is priced at US$13.94 per Class A ordinary share and is expected to close on November 19, 2025, subject to customary closing conditions [1]. - The net proceeds from the offering are estimated to be around US$148.4 million after deducting offering expenses [2]. - The offering is part of a broader strategy that includes a separate private offering of 4.00% Convertible Senior Notes due 2031, which is expected to generate approximately US$388.0 million in net proceeds [2]. Group 2: Use of Proceeds - Bitdeer plans to allocate approximately US$35.4 million of the proceeds to cover the costs of capped call transactions [3]. - An estimated US$267.9 million will be used to repurchase US$200.0 million of its 5.25% convertible senior notes due 2029 [3]. - Remaining proceeds will be directed towards datacenter expansion, ASIC-based mining rig development, and the growth of its HPC and AI cloud business, along with general corporate purposes [3]. Group 3: Transaction Contingencies - The completion of the registered direct offering is contingent upon the successful completion of the notes offering and the note repurchase transactions [4]. - The notes offering is not dependent on the completion of the registered direct offering or the note repurchase transactions [4]. Group 4: Company Overview - Bitdeer Technologies Group is a leading technology company specializing in Bitcoin mining and AI cloud solutions, providing comprehensive services including equipment procurement, datacenter design, and daily operations [7][8]. - The company is headquartered in Singapore and has established datacenters in the United States, Norway, and Bhutan [8].

Core Viewpoint - Bitdeer Technologies Group plans to offer Class A ordinary shares to holders of its 5.25% convertible senior notes due 2029 in a registered direct offering, subject to market conditions [1][2]. Group 1: Offering Details - The number of Class A ordinary shares and their price will be determined at the pricing of the registered direct offering [1]. - The registered direct offering is contingent on the completion of a separate notes offering and note repurchase transactions [2]. - Barclays Capital Inc. is acting as the placement agent, while ICR Capital LLC serves as the financial advisor for the offering [4]. Group 2: Use of Proceeds - Net proceeds from the registered direct offering will be used, along with proceeds from a separate notes offering, to repurchase a portion of the November 2029 notes [2]. Group 3: Company Overview - Bitdeer is a leading technology company specializing in Bitcoin mining and AI cloud solutions, providing comprehensive services including equipment procurement, logistics, datacenter design, and operations [5]. - The company is headquartered in Singapore and has datacenters in the United States, Norway, and Bhutan [5].

Group 1: Toast, Inc. (NYSE: TOST) - Jim Cramer expressed interest in buying shares of Toast, Inc. but advised waiting for the earnings report on November 4 [1] - Citigroup analyst Bryan Keane initiated coverage on Toast with a Buy rating and a price target of $51 [1] - Wells Fargo analyst Jason Kupferberg also initiated coverage with an Overweight rating and a price target of $47 [1] Group 2: Energy Transfer LP (NYSE: ET) - Cramer has a favorable view of Energy Transfer, which recently increased its quarterly dividend from $0.33 to $0.3325 per share [2] - Energy Transfer shares fell 0.4% to settle at $16.93 [4] Group 3: Datavault AI Inc. (NASDAQ: DVLT) - Cramer noted that Datavault AI is "losing money hand over fist" and suggested reducing holdings while allowing the rest to run [2] - Datavault AI raised $2.5 million through a registered direct offering, selling shares at $0.34 and $0.47 [2] - Datavault AI shares dipped 17.3% to settle at $2.67 [4]

Core Viewpoint - Annovis Bio, Inc. has announced a registered direct offering of 1,670,732 shares of its common stock at a price of $2.05 per share, aiming to raise approximately $3.4 million for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering price of $2.05 per share reflects the closing price on October 24, 2025 [1]. - The total gross proceeds from the offering are expected to be around $3.4 million before deducting fees and expenses [2]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering [2]. Group 2: Company Background - Annovis Bio is focused on developing therapies for neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD) [5]. - The company is headquartered in Malvern, Pennsylvania, and is committed to improving patient outcomes and quality of life through innovative therapies [5]. Group 3: Regulatory Information - The securities are being offered under a "shelf" registration statement previously filed with the SEC, which became effective on February 12, 2024 [3]. - A prospectus supplement related to the offering will be filed with the SEC and will be available on their website [3].

Core Viewpoint - Robin Energy Ltd. has announced a securities purchase agreement to raise approximately $7.0 million through the sale of 6,540,000 common shares at an offering price of $1.07 per share [1][2]. Group 1: Offering Details - The offering is being conducted with a single institutional investor and is expected to close on or about October 27, 2025, pending customary closing conditions [2]. - Maxim Group LLC is acting as the sole placement agent for the offering [2]. - The proceeds from the offering will be used for working capital and general corporate purposes [2]. Group 2: Regulatory Information - The offering is made pursuant to an effective shelf registration statement on Form F-3, which was declared effective by the U.S. Securities and Exchange Commission on April 28, 2025 [3]. - A prospectus supplement related to the securities will be filed with the SEC, and copies will be available on the SEC's website [3]. Group 3: Company Overview - Robin Energy Ltd. is an international ship-owning company that provides energy transportation services globally, operating a fleet that includes two LPG carriers and one Handysize tanker vessel [5].

Core Viewpoint - Univest Securities has successfully closed a registered direct offering of approximately $25 million for UTime Limited, a consumer electronics and mobile device manufacturer specializing in smartphones and related accessories [1][3]. Group 1: Offering Details - UTime Limited has agreed to sell 22,727,275 units to five institutional investors, with each unit consisting of one Class A ordinary share and one Series A warrant, at a purchase price of $1.10 per unit [2]. - The total gross proceeds from the offering were approximately $25 million before deducting fees and expenses [3]. - The offering was conducted under a shelf registration statement previously filed and declared effective by the SEC [4]. Group 2: Company Overview - UTime Limited specializes in the design, development, and manufacture of smartphones, feature phones, and related accessories, providing end-to-end product solutions [7]. - The company's principal business activities include contract manufacturing, in-house development of smart devices, integration of new technologies like IoT and 5G, and supply-chain management services [7]. Group 3: Univest Securities Overview - Univest Securities, LLC is a full-service investment bank and securities broker-dealer, providing a variety of financial services globally [6]. - Since 2019, Univest has raised over $1.5 billion in capital for issuers and completed approximately 100 transactions across various industries [6].

Core Viewpoint - Vivakor, Inc. has entered into a securities purchase agreement for the sale of 8,417,645 shares of common stock and 14,689,851 pre-funded warrants, aiming to raise approximately $5 million for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering is priced at-the-market under Nasdaq rules and is expected to close on or about October 17, 2025, pending customary closing conditions [1]. - The gross proceeds from the offering are approximately $5 million before deducting placement agent fees and other expenses [2]. - D. Boral Capital LLC is acting as the exclusive placement agent for this offering [2]. Group 2: Company Overview - Vivakor operates in two main business segments: crude oil transportation services and facility services for terminaling and storage of crude oil and its byproducts [5]. - The transportation services include trucking and pipeline transportation of crude oil, primarily in active regions such as Colorado's DJ Basin, Central Oklahoma's STACK play, and the Permian and Eagle Ford Basins of Texas [6]. - The Omega Gathering Pipeline is a 45-mile crude oil gathering and shuttle pipeline in Blaine County, Oklahoma, connected to the Cushing storage hub [6].

Core Viewpoint - Annovis Bio, Inc. has announced a registered direct offering to sell 4,000,000 shares of its common stock at a price of $1.50 per share, aiming to raise approximately $6 million for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering is expected to close around October 13, 2025, pending customary closing conditions [1]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for this offering [2]. - The gross proceeds from the offering are anticipated to be about $6 million before deducting fees and expenses [2]. Group 2: Regulatory Information - The securities are being offered under a "shelf" registration statement on Form S-3, which was filed with the SEC on February 1, 2024, and declared effective on February 12, 2024 [3]. - A prospectus supplement and base prospectus related to the offering will be filed with the SEC and made available on their website [3]. Group 3: Company Overview - Annovis Bio is focused on developing therapies for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, with a commitment to improving patient outcomes [5].